Marinus Pharmaceuticals Inc (MRNS) - Rasio rega marang prakiraan pendapatan
The forward P/S trend on this GURU.Markets chart has stabilized at 1.00, correlating with the commercial promotion of Ztalmy and expansion into global markets. Marinus Pharmaceuticals is currently optimizing expenses and narrowing its R&D pipeline to secure approval for oral ganaxolone. Revenues for Marinus Pharmaceuticals are based on the sale of genetic epilepsy medications and the development of hospital-grade pharmaceuticals.
Rincian metrik komprehensif lan analitis marinuspharma.com (MRNS)
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Marinus Pharmaceuticals|MRNS - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Marinus Pharmaceuticals Inc|MRNS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Marinus Pharmaceuticals|MRNS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Marinus Pharmaceuticals|Rasio cepet marinuspharma.com
- rincian asil keuangan lan kelipatan valuasi:
MRNS - Penghasilan resik perusahaan|Bathi mangsa ngarep Marinus Pharmaceuticals|MRNS - Pangali P/E|Prakiraan rega marang bathi Marinus|MRNS - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Marinus|MRNS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Marinus Pharmaceuticals|MRNS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan marinuspharma.com|MRNS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Marinus Pharmaceuticals
- statistik dodolan lan pendapatan perusahaan:
Analisis kabeh metrik perusahaan:Marinus Pharmaceuticals Inc MRNS
The forward P/S ratio compares the market value of Marinus Pharmaceuticals (MRNS) to projected revenue, allowing for an assessment of the premium paid for future growth and the determination of the investment's margin of safety. By analyzing the forward P/S history, an investor can see how patent protection for steroid drugs and the orphan drug status of seizure medications support a high business valuation while minimizing the risks of generic expansion.
Pesaing Marinus Pharmaceuticals
Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Pharma|SUPN: Rega forward marang dodolan|Multiplikator Forward P/S CPRX|Multiplikator Forward P/S denalitherapeutics.com (DNLI)|Multiplikator Forward P/S HRMY (Harmony Biosciences Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Biohaven (BHVN)|Amylyx Corp - Multiplikator Forward P/S|TRVI - Multiplikator Forward P/S|Praxis Precision Medicines Inc (PRAX) - Rasio rega marang prakiraan pendapatan|AVXL - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CeriBell|Multiplikator Forward P/S Prothena Corporation plc|Rasio rega marang prakiraan pendapatan Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan omeros.com OMER|neurogene.com (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|acimmune.com - Multiplikator Forward P/S|Voyager Therapeutics Inc (VYGR) - Multiplikator forward rega marang pendapatan|Neumora Corp (NMRA) - Rasio rega marang prakiraan pendapatan|Scilex Holding Company, Inc. (SCLX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TVGN|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alpha Cognition Inc. ACOG|Rasio rega marang prakiraan pendapatan cogrx.com (CGTX)|Rasio kapitalisasi marang dodolan sing dikarepake Inhibikase Therapeutics, Inc.|Multiplikator Forward P/S SAVA (Cassava Sciences Inc)|Multiplikator Forward P/S Assertio Holdings, Inc. ASRT|COYA - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Vistagen (VTGN)|OVID: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Acumen Pharmaceuticals Inc. (ABOS)|Multiplikator forward rega marang pendapatan CRVO|Kapitalisasi marang prakiraan pendapatan ATHE (Alterity Therapeutics)|Rasio rega marang prakiraan pendapatan Clene Nanomedicine (CLNN)|PEPG (PepGen) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|Rega forward marang dodolan RLMD|ANVS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grace Therapeutics Inc|AIFF: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Klotho Neurosciences Inc (KLTO)|Rasio rega marang prakiraan pendapatan neurosense-tx.com|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Reviva Pharmaceuticals Holdings Inc. RVPH|Rasio rega marang prakiraan pendapatan MetaVia Inc. (MTVA)|Rasio kapitalisasi marang dodolan sing dikarepake NeurAxis Inc|Multiplikator Forward P/S HSDT (heliusmedical.com)|Rega forward marang dodolan PASG|NEUP: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Minerva Neurosciences Inc|Athira Pharma (ATHA) - Rasio rega marang prakiraan pendapatan|Addex Therapeutics, Ltd. - Rega forward marang dodolan|ALZN (Alzamend Neuro) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep cyclerion.com CYCN|Multiplikator Forward P/S PTIX|KTTA - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BCLI - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep caratherapeutics.com|CHRO: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Longboard|Multiplikator Forward P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S
